Publications by authors named "Barbara Coco"

Claim this Profile
T
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm.
Gian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, Giulio Mengozzi, Alessia Ciancio, Barbara Coco

Liver Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Francesca Terracciani, Antonio De Vincentis, Daphne D'Amato, Laura Cristoferi, Alessio Gerussi, Barbara Coco

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of two transient elastography (TE) systems for measuring liver stiffness in clinical practice.
Simone Cappelli, Antonio Salvati, Giovanni Petralli, Laura De Rosa, Gabriele Ricco, Barbara Coco

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA.
Gian Paolo Caviglia, Piero Fariselli, Roberta D'Ambrosio, Piero Colombatto, Elisabetta Degasperi, Barbara Coco

Aliment Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary sclerosing cholangitis: Is qualitative and quantitative 3 T MR imaging useful for the evaluation of disease severity?
Piero Boraschi, Valentina Mazzantini, Francescamaria Donati, Barbara Coco, Barbara Vianello

Eur J Radiol Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients.
Elisa Ceccherini, Antonio Morlando, Francesco Norelli, Barbara Coco, Massimo Bellini

Molecules· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort.
Loreta A Kondili, Giuseppina Brancaccio, Maria Elena Tosti, Barbara Coco, Maria Giovanna Quaranta

Int J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B.
Andrea Vecchi, Marzia Rossi, Camilla Tiezzi, Paola Fisicaro, Sara Doselli, Barbara Coco

Gut· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Utility of the Saliva Proteome in Rare Diseases: A Pilot Study for Biomarker Discovery in Primary Sclerosing Cholangitis.
Elisa Ceccherini, Elena Michelucci, Giovanni Signore, Barbara Coco, Michela Zari

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection.
Daniela Cavallone, Eric David B Ornos, Gabriele Ricco, Filippo Oliveri, Barbara Coco

Viruses· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Unexpected Case of Infection Revealed during Liver Transplantation.
Valentina D Mangano, Daniela Campani, Andrea Cacciato Insilla, Barbara Coco, Maria Angeles Gomez Morales

Pathogens· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly dynamic changes of regional HBV epidemiology over two decades.
Gabriele Ricco, Barbara Coco, Piero Colombatto, Filippo Oliveri, Daniela Cavallone

Dig Liver Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination.
Giuseppina Brancaccio, Barbara Coco, Alessandra Nardi, Maria Giovanna Quaranta, Maria Elena Tosti

Int J Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer.
Luciana Puleo, Laura Agate, Irene Bargellini, Giuseppe Boni, Paolo Piaggi, Barbara Coco

Eur Thyroid J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Antonio De Vincentis, Daphne D'Amato, Laura Cristoferi, Alessio Gerussi, Federica Malinverno, Barbara Coco

Liver Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary biliary cholangitis: perception and expectation of illness.
Annarosa Floreani, Michela Scaffidi, Barbara Coco, Edoardo Giovanni Giannini, Sara Labanca

Dig Liver Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Loreta A Kondili, Monica Monti, Maria Giovanna Quaranta, Laura Gragnani, Valentina Panetta, Barbara Coco

Hepatology· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study.
Francesca Gorini, Michele Santoro, Anna Pierini, Lorena Mezzasalma, Silvia Baldacci, Barbara Coco

Front Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy.
Piero Colombatto, Elena Palmisano, Gabriele Ricco, Daniela Cavallone, Filippo Oliveri, Barbara Coco

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine.
Piero Colombatto, Barbara Coco, Ferruccio Bonino, Maurizia R Brunetto

Viruses· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib.
Piero Colombatto, Coskun Ozer Demirtas, Gabriele Ricco, Luigi Civitano, Piero Boraschi, Barbara Coco

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
Daniela Cavallone, Gabriele Ricco, Filippo Oliveri, Piero Colombatto, Francesco Moriconi, Barbara Coco

Aliment Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
Maria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, Roberto Filomia, Elisa Biliotti, Barbara Coco

Hepatol Int· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Carolina Boni, Harry L A Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Barbara Coco

Gastroenterology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Carolina Boni, Andrea Vecchi, Marzia Rossi, Diletta Laccabue, Tiziana Giuberti, Barbara Coco

Gastroenterology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis